| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Lifevantage Corporation$6.25
+0.01 (+0.16%)
Market Cap
70.77 M
EPS
0.46
P/E Ratio
12.61 $
Value Trade
7.63 M
SEC Financials
Q1 2026Dilution Risk
Revenue
43.72 M
R&D Expenses
200.00 K
Total Assets
62.13 M
Total Liabilities
28.79 M
Equity
33.34 M
D/E Ratio
12,345
11.75 %
Week
14.02 %
1 Month
11.31 %
3 Month
-11.37 %
6 Month
-32.73 %
5 Year
-80.35 %
All Time
Cash Data
Cash Position
12.48 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 6, 2026
Overview
Volume
125.56 K
52 Week Range
3.90 - 15
% held by Insiders
16.99 %
% held by Institutions
61.7 %
Enterprise Value
68.50 M
Total Shares
12.81 M
Short %
28.02 %
Float Shares
10.08 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Lifevantage Corporation
101Total events
1Upcoming
2Tier-1 (high impact)
2009 – 2026Coverage
Upcoming catalysts 1
Event history 100
May 6, 2026
◆Quarterly UpdateCorporate
Fiscal 2026 revenue, adjusted EBITDA, and adjusted EPS expected near lower end of prior guidance range
Mar 13, 2017
Jan 19, 2017
Dec 12, 2016
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in LFVN
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
LFVN Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
LFVN▲ +9.3%on this news
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026 Salt Lake City, UT
LifeVantage Corporation (Nasdaq: LFVN) reported third-quarter fiscal 2026 results, showing a revenue decline of 25.2% compared to the same period last year, primarily attributed to reduced sales of its MindBody GLP-1 System. The company's net income per diluted share dropped to $0.11, down from $0.26, while adjusted EBITDA also fell significantly. Despite these challenges, LifeVantage emphasized its strong balance sheet, share repurchase activities, and an increase in its cash dividend. The company aims to enhance performance through strategic initiatives and product launches moving forward.
Read more →LFVN▲ +5.1%on this news
LifeVantage Appointing Terrence Moorehead as Chief Executive Officer Salt Lake City, UT
LifeVantage Corporation has appointed Terrence Moorehead as the new President and Chief Executive Officer, effective August 5, 2026. Moorehead, who has over 25 years of experience in leading transformations within the health and wellness industry, previously served as CEO of Nature's Sunshine Products, where he achieved significant revenue and EBITDA growth. His appointment follows the planned retirement of the former CEO, Steve Fife, and the Board expresses confidence in Moorehead's ability to guide the company through its next phase of growth. The interim leadership team will maintain operations until Moorehead officially joins the company.
Read more →LFVNDocument LifeVantage Appoints Cindy Latham to Board of Directors Salt Lake City, UT
LifeVantage Appoints Cindy Latham to Board of Directors Salt Lake City, UT, February 17, 2022, (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq LFVN) today announced the appointment of Cindy Latham to the Company's Board of Directors. Latham is a senior-level marketing execut
Read more →LFVNDocument LifeVantage Appoints Carl Aure as Chief Financial Officer Salt Lake City, UT
LifeVantage Appoints Carl Aure as Chief Financial Officer Salt Lake City, UT, October 25, 2021, (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq LFVN) today announced the appointment of Carl Aure as Chief Financial Officer. Mr. Aure brings more than 24 years of finance and ac
Read more →LFVNDocument LifeVantage Announces Appointment of Chief Executive Officer Steven R. Fife Named President, CEO Director Salt Lake City, UT
LifeVantage Announces Appointment of Chief Executive Officer Steven R. Fife Named President, CEO Director Salt Lake City, UT, February 2, 2021, (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq LFVN) announced today that its Board of Directors has named Steven Fife as Preside
Read more →LFVNDocument LifeVantage Announces Management Transition Steven Fife Appointed Interim Chief Executive Officer Justin Rose to Lead Combined Sales Marketing Team Reiterates Fiscal 2021 Guidance Salt Lake City, UT
LifeVantage Announces Management Transition Steven Fife Appointed Interim Chief Executive Officer Justin Rose to Lead Combined Sales Marketing Team Reiterates Fiscal 2021 Guidance Salt Lake City, UT, September 8, 2020, (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq LFVN)
Read more →LFVNLifeVantage Reports Record Second Quarter Preliminary Revenue
LifeVantage Reports Record Second Quarter Preliminary Revenue Q2 preliminary revenue of approximately $58 million represents the highest quarterly revenue in the company's history Revenue increased approximately 17% year over year and 4% sequentially Salt Lake City, UT, Januar
Read more →LFVNThis Indemnification Agreement, effective as of _____ __, ____, is made between LifeVantage Corporation, a Delaware corporation (the "Company"), and _________ (the "Indemnitee").
LifeVantage Corporation INDEMNIFICATION AGREEMENT This Indemnification Agreement, effective as of _____ __, ____, is made between LifeVantage Corporation, a Delaware corporation (the "Company"), and _________ (the "Indemnitee"). A.The Company desires to attract and retain the
Read more →LFVNThis document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
LifeVantage Further Enhances Management Team with Appointment of Steven R. Fife as Chief Financial Officer SALT LAKE CITY, March 13, 2017 - LifeVantage Corporation (Nasdaq:LFVN), announced today the appointment of Steven R. Fife as Chief Financial Officer, effective immediately
Read more →LFVNLifeVantage Announces Management Change
LifeVantage Announces Management Change Gary Koos to Assume Role as Interim Chief Financial Officer SALT LAKE CITY, January 18, 2017 - LifeVantage Corporation (Nasdaq:LFVN), announced today the appointment of Gary Koos as Interim Chief Financial Officer, effective January 19, 2
Read more →LFVNLifeVantage Announces Financial Results for Fiscal Year 2016 and the First Quarter of Fiscal 2017
LifeVantage Announces Financial Results for Fiscal Year 2016 and the First Quarter of Fiscal 2017 Company files Forms 10-K and 10-Q for periods ended June 30, 2016 and September 30, 2016, respectively Expects to regain compliance with Nasdaq listing rules First Quarter of Fis
Read more →LFVNLifeVantage Corp.
LifeVantage Corp. Receives NASDAQ Letter Related to Delay in Filing Form 10-Q SALT LAKE CITY, UT, November 18, 2016 - LifeVantage Corporation (NASDAQ: LFVN) announced today that in connection with its November 10, 2016 notification of late filing of the Company's Form 10-Q for t
Read more →LFVNLifeVantage Receives Limited Waiver and Extension Under Credit Facility
LifeVantage Receives Limited Waiver and Extension Under Credit Facility SALT LAKE CITY, UT, October 26, 2016 - LifeVantage Corporation (NASDAQ: LFVN) announced today that it has received a limited waiver and extension from Zions Bank, the lender under the company's credit facili
Read more →LFVNLifeVantage Appoints WSRP, LLC as its New Independent Auditor
LifeVantage Appoints WSRP, LLC as its New Independent Auditor The Company dismissed BDO USA, LLP as its independent auditor due to BDO USA's determination that it was not independent of the Company with respect to fiscal 2016 Salt Lake City, UT, July 13, 2016, LifeVantage Corpo
Read more →LFVNLifeVantage Announces Third Quarter Fiscal Year 2016 Results
LifeVantage Announces Third Quarter Fiscal Year 2016 Results Reports Record Quarterly Revenue of $56.2 Million Third Quarter Revenue Increased 24.4% year over year Third Quarter Americas Revenue increased 33.8% year over year Company Narrows Fiscal 2016 Guidance Salt Lake Ci
Read more →LFVNLifeVantage Announces Refinancing of Term Loan
LifeVantage Announces Refinancing of Term Loan New three-year term loan with Zions Bank provides reduced interest rate and extended maturity Salt Lake City, UT, April 4, 2016, LifeVantage Corporation (Nasdaq: LFVN), announced today that it has entered into a new $10 million thr
Read more →LFVNLifeVantage Announces Second Quarter Fiscal Year 2016 Results
LifeVantage Announces Second Quarter Fiscal Year 2016 Results Second Quarter Revenue Increased 7.8% to $52 Million Compared to Same Period Last Year Revenue in the Americas and Asia/Pacific increased 15.3% and 12.4% on a Sequential Basis Revenue in Japan increased 7.3% on a Se
Read more →LFVNLifeVantage Announces First Quarter Fiscal Year 2016 Results
LifeVantage Announces First Quarter Fiscal Year 2016 Results First Quarter Revenue was $45.4 Million Adjusted EBITDA Increased 43% sequentially to $4.5 million in First Quarter Company Reiterates Fiscal 2016 Guidance Announced New Products Announced Plan for Expansion into E
Read more →LFVNLifeVantage Announces 7:1 Reverse Stock Split
LifeVantage Announces 7:1 Reverse Stock Split -Company Reiterates Fiscal Year 2016 Guidance - Salt Lake City, UT, October 16, 2015, LifeVantage Corporation (NASDAQ: LFVN) ("LifeVantage" or the "Company") today announced a 7:1 reverse split of its common stock, which is expected
Read more →LFVNEARNINGS RELEASE Exhibit LifeVantage Announces Fourth Quarter and Full Fiscal Year 2015 Results Full Fiscal Year 2015 Revenue was $190.3 Million Generated $17.4 Million Adjusted EBITDA and $7.0 Million Net Income in Fisc
LifeVantage Announces Fourth Quarter and Full Fiscal Year 2015 Results Full Fiscal Year 2015 Revenue was $190.3 Million Generated $17.4 Million Adjusted EBITDA and $7.0 Million Net Income in Fiscal Year 2015 Company Provides Fiscal 2016 Guidance; Expects to Achieve Increased R
Read more →LFVNLifeVantage Appoints Mark Jaggi New Chief Financial Officer
LifeVantage Appoints Mark Jaggi New Chief Financial Officer Salt Lake City, UT, August 24, 2015, LifeVantage Corporation (Nasdaq: LFVN), announced today that Mark Jaggi has been appointed Chief Financial Officer for the company effective August 24, 2015. Mr. Jaggi is a highly e
Read more →LFVNLifeVantage Announces Third Quarter Fiscal Year 2013 Results
LifeVantage Announces Third Quarter Fiscal Year 2013 Results Third Quarter Net Revenue Increased 39% Over Prior Year Period to $50.4 Million Independent Distributors Grew 19% in Third Quarter, 2013 Compared to Second Quarter, 2013 Company Generated Net Income of $3.4 Million
Read more →LFVNLifeVantage Announces Additional Share Repurchase Program Company s Board Authorizes Repurchase of an Additional $5 Million of its Common Stock Board of Directors is Exploring Options to Reduce Outstanding Shares Salt La
LifeVantage Announces Additional Share Repurchase Program Company s Board Authorizes Repurchase of an Additional $5 Million of its Common Stock Board of Directors is Exploring Options to Reduce Outstanding Shares Salt Lake City, UT, March 22, 2013, LifeVantage Corporation (NAS
Read more →LFVNLifeVantage Announces Second Quarter Fiscal Year 2013 Results Second Quarter Net Revenue Increased 111% Over Prior Year Period to $53.4 Million Second Quarter Operating Cash Flow Grew 16% Over Prior Year Period to $5.4 M
LifeVantage Announces Second Quarter Fiscal Year 2013 Results Second Quarter Net Revenue Increased 111% Over Prior Year Period to $53.4 Million Second Quarter Operating Cash Flow Grew 16% Over Prior Year Period to $5.4 Million Company Reiterates Full Year Fiscal 2013 Revenue G
Read more →LFVNLifeVantage Launches Protandim, the Nrf2 Synergizer in Japan In Country Operations Formally Underway
LifeVantage Launches Protandim, the Nrf2 Synergizer in Japan In Country Operations Formally Underway SALT LAKE CITY, January 14, 2013 LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling busine
Read more →LFVNLifeVantage Formally Expands its Global Operations to Hong Kong
LifeVantage Formally Expands its Global Operations to Hong Kong SALT LAKE CITY, December 19, 2012 LifeVantage Corporation (NASDAQ:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically va
Read more →LFVNLifeVantage Announces Shares Repurchase Program Company authorized repurchase of up to $5 million in shares of its common stock
LifeVantage Announces Shares Repurchase Program Company authorized repurchase of up to $5 million in shares of its common stock SALT LAKE CITY, December 14, 2012 LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combi
Read more →LFVNWedbush 13th Annual Consumer Conference
Safe Harbor Statement This presentation contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as w
Read more →LFVNLifeVantage Corporation Announces Voluntary Recall and Replacement of Select Lots of Protandim Dietary Supplement Due to Potential Health Risk Contact: Customer Care: 866-912-9051
LifeVantage Corporation Announces Voluntary Recall and Replacement of Select Lots of Protandim Dietary Supplement Due to Potential Health Risk CITY, December 5, 2012 (GLOBE NEWSWIRE) LifeVantage Corporation (NASDAQ: LFVN) announced today that it is contacting affected independe
Read more →LFVNLifeVantage Announces Dismissal of Lawsuit
LifeVantage Announces Dismissal of Lawsuit SALT LAKE CITY, November 14, 2012 (GLOBE NEWSWIRE) LifeVantage Corporation (NASDAQ:LFVN), announced today that on November 13, 2012, the Plaintiff in the lawsuit entitled Bramwell v. LifeVantage Corporation, et al (No. 12 Civ. 1006 (DB
Read more →LFVNLifeVantage Announces Strong First Quarter Fiscal Year 2013 Results First Quarter Net Revenue Increases 163% Over Prior Year Period to $52.9 Million First Quarter Operating Income Improves to $6.9 Million Company Reitera
LifeVantage Announces Strong First Quarter Fiscal Year 2013 Results First Quarter Net Revenue Increases 163% Over Prior Year Period to $52.9 Million First Quarter Operating Income Improves to $6.9 Million Company Reiterates Full Year Fiscal 2013 Revenue, Operating Margin, and
Read more →LFVNLifeVantage Corporation Announces Appointment of Head of Asia Operations Company Appoints David Toda as New President and Managing Director, Asia Pacific Salt Lake City, UT
LifeVantage Corporation Announces Appointment of Head of Asia Operations Company Appoints David Toda as New President and Managing Director, Asia Pacific Salt Lake City, UT, October 25, 2012, LifeVantage Corporation (NASDAQ:LFVN), a company dedicated to helping people achieve
Read more →LFVNLifeVantage Appoints Darlene R. Walley Ph.D. as New Chief Science Officer Company Expands Research and Product Development for Future Growth Opportunities Salt Lake City, UT
LifeVantage Appoints Darlene R. Walley Ph.D. as New Chief Science Officer Company Expands Research and Product Development for Future Growth Opportunities Salt Lake City, UT, October 12, 2012, LifeVantage Corporation (NASDAQ: LFVN), a company dedicated to helping people achiev
Read more →LFVNLifeVantage Announces Continued International Expansion Salt Lake City, UT
LifeVantage Announces Continued International Expansion Salt Lake City, UT, September 19, 2012, LifeVantage Corporation (LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated p
Read more →LFVNLifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results Company Receives Approval to List on The Nasdaq Capital Market Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Milli
LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results Company Receives Approval to List on The Nasdaq Capital Market Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Million Quarter Operating Income Improves to a Record $7.3 Mil
Read more →LFVNLifeVantage Corporation Completes Previously Announced CFO Transition Company Appoints David Colbert as New Chief Financial Officer SALT LAKE CITY LifeVantage Corporation (OTCBB: LFVN), the leader in Nrf2 science and the
LifeVantage Corporation Completes Previously Announced CFO Transition Appoints David Colbert as New Chief Financial Officer SALT LAKE CITY LifeVantage Corporation (OTCBB: LFVN), the leader in Nrf2 science and the maker of Protandim , the Nrf2 Synergizer patented dietary supple
Read more →LFVNLifeVantage Announces Record Third Quarter Fiscal Year 2012 Net Revenue Increases 263% Over Prior Year Period to $36.2 Million Operating Income Improves to a Record $6.4 Million Company Raises Full Year Fiscal 2012 Reven
LifeVantage Announces Record Third Quarter Fiscal Year 2012 Net Revenue Increases 263% Over Prior Year Period to $36.2 Million Operating Income Improves to a Record $6.4 Million Company Raises Full Year Fiscal 2012 Revenue and Operating Margin Guidance Salt Lake City, UT, May
Read more →LFVNLifeVantage Corporation Makes Charitable Donation To Traffic Jam Salt Lake City, UT
LifeVantage Corporation Makes Charitable Donation To Traffic Jam Salt Lake City, UT, April 20, 2012, LifeVantage Corporation (OTCBB: LFVN), maker of Protandim , the Nrf2 Synergizer patented dietary supplement, announced today it has made a substantial charitable donation to Tra
Read more →LFVNLifeVantage Announces Record Second Quarter Fiscal Year 2012 Net Revenue Increases 239% Over Prior Year Period to $25.3 Million Operating Income Improves to a Record $4.3 Million Company Raises Full Year Fiscal 2012 Reve
LifeVantage Announces Record Second Quarter Fiscal Year 2012 Net Revenue Increases 239% Over Prior Year Period to $25.3 Million Operating Income Improves to a Record $4.3 Million Company Raises Full Year Fiscal 2012 Revenue and Operating Margin Guidance Salt Lake City, UT, Fe
Read more →LFVNLifeVantage to Announce Fiscal Second Quarter 2012 Results on
LifeVantage to Announce Fiscal Second Quarter 2012 Results on February 14, 2012 Salt Lake City, UT February 7, 2012 LifeVantage Corporation (OTCBB:LFVN), maker of Protandim , the Nrf2 Synergizer patented dietary supplement, announced today it will release financial results for t
Read more →LFVNLifeVantage Expands Board of Directors and Announces Approval of Tender Offer to Modify Warrants Nine Directors Including Four New Directors Elected at Company s Annual Meeting of Shareholders Board Appoints New Chairman
LifeVantage Expands Board of Directors and Announces Approval of Tender Offer to Modify Warrants Nine Directors Including Four New Directors Elected at Company s Annual Meeting of Shareholders Board Appoints New Chairman Salt Lake City, UT, January 17, 2012, LifeVantage Corpor
Read more →LFVNLIFEVANTAGE PROVIDES CORPORATE UPDATE Announces Adoption of Rule 10b5-1 Stock Repurchase Plan Anticipates Approval of Warrant Amendment to Remove Price-Based Anti-dilution Provisions Outlines Operational & Strategic Acco
LIFEVANTAGE PROVIDES CORPORATE UPDATE Announces Adoption of Rule 10b5-1 Stock Approval of Warrant Amendment to Remove Price-Based Anti-dilution Provisions Outlines Operational & Strategic Accomplishments and Guidance for 2012 Salt Lake City, UT, December 19, 2011, LifeVantag
Read more →LFVNLIFEVANTAGE ANNOUNCES RECORD FIRST QUARTER FISCAL YEAR 2012 RESULTS Net Revenue Increases Over 200% from the Prior Year Period to $20.1 Million Operating Income Improves to a Record $3.4 Million or 17% Operating Margin C
LIFEVANTAGE ANNOUNCES RECORD FIRST QUARTER FISCAL YEAR 2012 RESULTS Net Revenue Increases Over 200% from the Prior Year Period to $20.1 Million Operating Income Improves to a Record $3.4 Million or 17% Operating Margin Company Raises Full Year Fiscal 2012 Revenue and Operating
Read more →LFVNF INAL T RANSCRIPT Conference Call Transcript LFVN - Q4 2011 Lifevantage Corp Earnings Conference Call Event Date/Time
Conference Call Transcript LFVN - Q4 2011 Lifevantage Corp Earnings Conference Call Event Date/Time: Sep 28, 2011 Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call CORPORATE PARTICIPANTS IRC - Corporate Communications Corporation - Pres
Read more →LFVNLIFEVANTAGE ANNOUNCES RECORD FISCAL YEAR 2011 RESULTS AND PROVIDES FISCAL YEAR 2012 GUIDANCE Record Fourth Quarter Net Revenue Increases to $15.0 Million Generates Record Full Year Fiscal 2011 Operating Income of $3.7 Mi
LIFEVANTAGE ANNOUNCES RECORD FISCAL YEAR 2011 RESULTS AND PROVIDES FISCAL YEAR 2012 GUIDANCE Record Fourth Quarter Net Revenue Increases to $15.0 Million Record Full Year Fiscal 2011 Operating Income of $3.7 Million Company Strengthens Balance Sheet and Ends Fiscal 2011 with
Read more →LFVNLife Vantage Corporation investor Presentation Accredited Members Summer 2011 Investment Research Conference
TrueScience Anti-Aging Skin Cream Scientifically-based, unique skin care line launched in June 2009 Formulated to protect the skin from a variety of factors that contribute to aging and the symptoms of unhealthy skin Robust market potential for anti-aging skincare products Contai
Read more →LFVNLIFEVANTAGE ANNOUNCES FISCAL THIRD QUARTER 2011 RESULTS Record Third Quarter Net Revenue Increases to $10.0 Million Record Third Quarter Operating Income Improves to $792,000 Company Raises Fiscal Year 2011 Revenue Guida
LIFEVANTAGE ANNOUNCES FISCAL THIRD QUARTER 2011 Record Third Quarter Net Revenue Increases to $10.0 Million Record Third Quarter Operating Income Improves to $792,000 Raises Fiscal Year 2011 Revenue Guidance to Range of $37 $39 Million Raises Operating Income Guidance to Rang
Read more →LFVNLIFEVANTAGE ANNOUNCES APPOINTMENT OF NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER Douglas C. Robinson Brings Over 20 Years of Executive Financial Expertise San Diego , CA
LIFEVANTAGE ANNOUNCES APPOINTMENT OF NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER Douglas C. Robinson Brings Over 20 Years of Executive Financial Expertise San Diego, CA, March 14, 2011, LifeVantage Corporation (OTCBB: LFVN), the maker of science-based solutions to oxidative stre
Read more →LFVNLIFEVANTAGE ANNOUNCES PRELIMINARY UNAUDITED SECOND QUARTER 2011 RESULTS Company Anticipates Record Operating Profit on Highest Quarterly Net Revenue to Date San Diego , CA
LIFEVANTAGE ANNOUNCES PRELIMINARY UNAUDITED SECOND QUARTER 2011 RESULTS Company Anticipates Record Operating Profit on Highest Quarterly Net Revenue to Date Diego, CA, January 19, 2011, LifeVantage Corporation (OTCBB: LFVN), the maker of science-based solutions to oxidative st
Read more →LFVNLIFEVANTAGE ANNOUNCES UNAUDITED FIRST QUARTER FISCAL 2011 FINANCIAL AND OPERATING RESULTS Company Reports $345k Record Operating Profit on Revenue Increase of $4.6 million, or 247% over Same Quarter Last Year Conference
LIFEVANTAGE ANNOUNCES UNAUDITED FIRST QUARTER FISCAL 2011 FINANCIAL AND OPERATING RESULTS Company Reports $345k Record Operating Profit on Revenue Increase of $4.6 million, or 247% over Same Quarter Last Year Conference call scheduled for November 10, 2010 at 1:30pm (Pacific);
Read more →LFVNLIFEVANTAGE ANNOUNCES UNAUDITED SECOND QUARTER FISCAL 2010 FINANCIAL AND OPERATING RESULTS Company Records Increase of Over 30% in Net Revenue Over First Fiscal Quarter 2010 Conference call scheduled for
LIFEVANTAGE ANNOUNCES UNAUDITED SECOND QUARTER FISCAL 2010 FINANCIAL AND OPERATING RESULTS Company Records Increase of Over 30% in Net Revenue Over First Fiscal Quarter 2010 Conference call scheduled for March 2, 2010 at 1:30pm (Pacific); simultaneous webcast at Diego, CA, Feb
Read more →LFVNLIFEVANTAGE ANNOUNCES PRELIMINARY UNAUDITED FIRST QUARTER REVENUE Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue San Diego , CA
LIFEVANTAGE ANNOUNCES PRELIMINARY UNAUDITED FIRST QUARTER REVENUE Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue San Diego, CA, October 15, 2009, LifeVantage Corporation (OTCBB: LFVN), the maker of Protandim and TrueScience A
Read more →LFVNLIFEVANTAGE ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2009 FINANCIAL AND OPERATING RESULTS San Diego , CA
LIFEVANTAGE ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2009 FINANCIAL AND San Diego, CA, September 29, 2009, LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based s
Read more →Competitive Position
How LFVN ranks across every disease it competes inCompetitive Position is a premium feature
See how LFVN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial